FDA approval
Scope
Date
~
-
Bio & Pharma
Celltrion wins Australian approval for eye, bone disease biosimilars
Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...
Apr 10, 2025 (Gmt+09:00)
-
Bio & Pharma
Samsung, Celltrion lead biosimilar market in Europe, US
Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...
Mar 10, 2025 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins EU approval for autoimmune disease treatment Avtozma
Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...
Feb 25, 2025 (Gmt+09:00)
-
Robotics
Koh Young gets OK from FDA for brain surgery robot
Koh Young Technology Inc., a South Korean developer of 3D optical inspection devices used in electronics manufacturing, said on Monday it got 501K...
Jan 21, 2025 (Gmt+09:00)
-
Private equity
Korean lenders to Accell warn they may boycott KKR
KKR & Co. is facing a huge backlash from South Korean financial services firms after the debt restructuring of Dutch bicycle manufacturer Accell...
Jan 10, 2025 (Gmt+09:00)
-
Bio & Pharma
JLK gets OK from FDA for ICH diagnosis solution
South Korea’s JLK Inc., an AI-based diagnosis solution and platform maker, said on Monday it got 501K approval from the US Food and Drug Admin...
Jan 06, 2025 (Gmt+09:00)
-
Bio & Pharma
Yuhan’s lung cancer drug gets OK in Europe
Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...
Dec 31, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion obtains approval of Steqeyma from FDA
South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...
Dec 18, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s 4 new biosimilars win EU approval recommendation
Celltrion Inc. is one step closer to commercializing its four new biosimilars in Europe after a committee of the European Medicines Agency (EMA) rec...
Dec 16, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets approval of Omlyclo in Canada
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...
Dec 09, 2024 (Gmt+09:00)
-
Airlines
Korean Air gets EU approval for Asiana merger
The European Commission (EC), the European Union (EU) antitrust body, approved the merger between Korean Air Lines Co. and Asiana Airlines Inc. on N...
Nov 29, 2024 (Gmt+09:00)
-
Bio & Pharma
Noul's miLab registered FDA's Class I
South Korea's Noul Co., an in-vitro diagnostics maker and artificial intelligence (AI)-based blood and cancer diagnostic platforms company, said on ...
Nov 28, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis gets EC's approval for Opuviz
South Korea's Samsung Bioepis Co., Samsung Biologics Co.'s fully owned biosimilar subsidiary, and the US-based Biogen said on Tuesday the European C...
Nov 19, 2024 (Gmt+09:00)
-
Batteries
South Korea approves Korea Zinc’s precursor as national core technology
South Korea has designated Korea Zinc Inc.'s precursor manufacturing process as a national core technology and advanced industrial technology, effec...
Nov 19, 2024 (Gmt+09:00)
-
Food & Beverage
Samyang enters Australia, New Zealand with allulose approval
South Korean chemical and food ingredient manufacturer Samyang Corp. said on Wednesday that it has become the first allulose producer to secure appr...
Nov 13, 2024 (Gmt+09:00)
-
Bio & Pharma
ViGenCell obtains approval for HLA-B5801 genetic diagnostic kit for adverse reactions to gout treatment
ViGenCell, a company specializing in immunotherapy, announced on Friday that it has obtained approval from the Ministry of Food and Drug Safety (MFD...
Oct 25, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience's SKYCellflu approved in Indonesia
SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, said on Wednesday that The Indonesian Food and Drug Authority BPOM ...
Oct 24, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion establishes subsidiary in Vietnam
Celltrion Inc., South Korea’s largest biosimilar maker, said on Monday that it completed the establishment of a local subsidiary in Vietnam....
Sep 30, 2024 (Gmt+09:00)
-
Business & Politics
South Korea scraps anti-nuclear policy with approval of two nuclear plants
South Korea has approved the construction of two nuclear power plants, officially ending its anti-nuclear policy pursued by the previous Moon Jae-in...
Sep 13, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
SK Innovation-SK E&S merger gains shareholders’ nod
SK Innovation Co., South Korea’s largest energy company, has won majority support from its shareholders for a merger with its liquefied natura...
Aug 27, 2024 (Gmt+09:00)
-
Bio & Pharma
Yuhan’s lung cancer drug clears FDA hurdle for global debut
A new lung cancer treatment developed by South Korea’s Yuhan Corp. has secured approval from the US Food and Drug Administration (FDA) as a co...
Aug 21, 2024 (Gmt+09:00)
-
Aerospace & Defense
South Korea to extend export missile range from 300 km to 500 km
South Korea has decided to extend the range of missiles for export to 500 kilometers from the current 300 km after accepting requests to do so from ...
Aug 20, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets FDA nod for Keytruda copy's phase 3 clinical trials
Celltrion Inc., South Korea’s biosimilar giant, will proceed with phase 3 trials for global blockbuster drug Keytruda’s copycat CT-P51, ...
Aug 12, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets approval of Steqeyma in Canada
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Steqeyma, a biosimilar of the autoimmune dise...
Jul 31, 2024 (Gmt+09:00)
-
Food & Beverage
Lotte India, Havmor to merge to raise $722.4 mn in sales
South Korean confectionery giant Lotte Wellfood Co. will merge its Indian subsidiaries — Lotte India Co. and Havmor Ice Cream Pvt — to b...
Jul 30, 2024 (Gmt+09:00)
-
Corporate restructuring
Doosan Robotics, Bobcat merger prompts call for law revision
Doosan Group’s announcement of a merger between Doosan Robotics Inc. and Doosan Bobcat Inc. has met with strong criticism from investors and p...
Jul 22, 2024 (Gmt+09:00)
-
Shipping & Shipbuilding
Korea approves HD KSOE-STX Heavy merger with conditions
South Korea’s antitrust body has given a conditional nod to leading domestic shipyard HD Korea Shipbuilding & Offshore Engineering Co.'s (...
Jul 15, 2024 (Gmt+09:00)
-
Aerospace & Defense
S.Korea’s Hanwha, Doosan to develop fighter jet engines
Hanwha Aerospace Co., South Korea’s top defense manufacturer, and Doosan Enerbility Co., a major local power plant builder, are set to develop...
Jul 02, 2024 (Gmt+09:00)
-
Electronics
Solus to supply copper foil for AI accelerators to Nvidia
Solus Advanced Materials, a South Korean copper foil supplier, will provide copper foil for AI accelerators to Nvidia, a leading company in artifici...
Jul 01, 2024 (Gmt+09:00)
-
Bio & Pharma
JLK gets FDA OK for prostate cancer diagnosis AI solution
South Korea’s JLK Inc., an AI-based diagnosis solution and platform maker, announced on Monday that it got approval from the US Food and Drug ...
Jun 25, 2024 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand